Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Mericitabine

Catalog No. T16710Cas No. 940908-79-2
Alias RG 7128, R-7128, PSI 6130 diisobutyrate

Mericitabine (R-7128) is a nucleoside HCV NS5B polymerase inhibitor. It acts as an RNA chain terminator and prevents the elongation of RNA transcripts during replication.

Mericitabine

Mericitabine

Purity: 98.1%
Catalog No. T16710Alias RG 7128, R-7128, PSI 6130 diisobutyrateCas No. 940908-79-2
Mericitabine (R-7128) is a nucleoside HCV NS5B polymerase inhibitor. It acts as an RNA chain terminator and prevents the elongation of RNA transcripts during replication.
Pack SizePriceAvailabilityQuantity
1 mg$45In Stock
5 mg$110In Stock
10 mg$153In Stock
25 mg$265In Stock
50 mg$389In Stock
100 mg$556In Stock
200 mg$758In Stock
1 mL x 10 mM (in DMSO)$118In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Mericitabine"

Select Batch
Purity:98.1%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Mericitabine (R-7128) is a nucleoside HCV NS5B polymerase inhibitor. It acts as an RNA chain terminator and prevents the elongation of RNA transcripts during replication.
In vitro
PSI-6130 is converted through phosphorylation by cellular kinases to an active 5′-triphosphate metabolite, which inhibits the NS5B RNA polymerase of HCV. Mericitabine is an oral cytidine nucleoside analog prodrug that exhibits strong antiviral effectiveness against the HCV polymerase across all HCV genotypes. Mericitabine is a first-in-class nucleoside polymerase inhibitor (NPI), which requires intracellular uptake and phosphorylation to two active triphosphates. Mericitabine, a cytidine analogue, is an oral prodrug of PSI-6130. PSI-6130 has an EC90 value of 4.6±2 μM in the HCV replicon assay. Mericitabine displays high specificity for HCV, minimal cytotoxicity, and does not affect mitochondrial DNA. Mericitabine shows a relatively good safety profile and significant potency against HCV-1 [2][3].
AliasRG 7128, R-7128, PSI 6130 diisobutyrate
Chemical Properties
Molecular Weight399.41
FormulaC18H26FN3O6
Cas No.940908-79-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (250.37 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5037 mL12.5185 mL25.0369 mL125.1846 mL
5 mM0.5007 mL2.5037 mL5.0074 mL25.0369 mL
10 mM0.2504 mL1.2518 mL2.5037 mL12.5185 mL
20 mM0.1252 mL0.6259 mL1.2518 mL6.2592 mL
50 mM0.0501 mL0.2504 mL0.5007 mL2.5037 mL
100 mM0.0250 mL0.1252 mL0.2504 mL1.2518 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Mericitabine | purchase Mericitabine | Mericitabine cost | order Mericitabine | Mericitabine chemical structure | Mericitabine in vitro | Mericitabine formula | Mericitabine molecular weight